{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:42:13Z","timestamp":1707525733797},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,19]]},"DOI":"10.7759\/cureus.52585","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T20:52:16Z","timestamp":1705697536000},"source":"Crossref","is-referenced-by-count":0,"title":["A Presentation of Babesiosis in the Setting of Low-Grade Follicular B-cell Lymphoma"],"prefix":"10.7759","author":[{"given":"Erika","family":"Foerst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthik","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arezoo","family":"Ghaneie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"A framework for signaling throughout the life cycle of Babesia species. (2020). Accessed. January 13, 2024: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/mmi.14650."},{"key":"ref2","article-title":"Babesiosis: clinical manifestations and diagnosis","author":"Krause","year":"2022","unstructured":"Krause, PJ, Vannier EG. Babesiosis: clinical manifestations and diagnosis. UpToDate. Baron EL (ed): Wolters Kluwer, Philadelphia, PA; 2022."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019015","article-title":"Clinical analysis of 20 patients with non-Hodgkin lymphoma and autoimmune hemolytic anemia: A retrospective study","volume":"99","author":"Zhou JC","year":"2020","unstructured":"Zhou JC, Wu MQ, Peng ZM, Zhao WH, Bai ZJ. Clinical analysis of 20 patients with non-Hodgkin lymphoma and autoimmune hemolytic anemia: A retrospective study. Medicine (Baltimore). 2020, 99:e19015. 10.1097\/MD.0000000000019015","journal-title":"Medicine (Baltimore)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.03.046","article-title":"Lyme disease: part I. Advances and perspectives","volume":"64","author":"Bhate C","year":"2011","unstructured":"Bhate C, Schwartz RA. Lyme disease: part I. Advances and perspectives. J Am Acad Dermatol. 2011, 64:619-36; quiz 637-8. 10.1016\/j.jaad.2010.03.046","journal-title":"J Am Acad Dermatol"},{"key":"ref5","article-title":"Rocky Mountain Spotted Fever (Rickettsia rickettsii)","author":"Snowden J","year":"2023","unstructured":"Snowden J, Simonsen KA. Rocky Mountain Spotted Fever (Rickettsia rickettsii). StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1515\/biol-2022-0448","article-title":"Babesia microti-induced fulminant sepsis in an immunocompromised host: a case report and the case-specific literature review","volume":"17","author":"Conte HA","year":"2022","unstructured":"Conte HA, Biondi MC, Janket SJ, Ackerson LK, Diamandis EP. Babesia microti-induced fulminant sepsis in an immunocompromised host: a case report and the case-specific literature review. Open Life Sci. 2022, 17:1200-7. 10.1515\/biol-2022-0448","journal-title":"Open Life Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00063-008-1014-2","article-title":"[Babesiosis in an immunocompromised German patient]","volume":"103","author":"H\u00e4selbarth K","year":"2008","unstructured":"H\u00e4selbarth K, Kurz M, Hunfeld KP, Krieger G. [Babesiosis in an immunocompromised German patient]. Med Klin (Munich). 2008, 103:104-7. 10.1007\/s00063-008-1014-2","journal-title":"Med Klin (Munich)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2019.04.026","article-title":"Heavy parasitemia in babesiosis treated without adjunctive red cell exchange","volume":"58","author":"Cervera-Hernandez ME","year":"2019","unstructured":"Cervera-Hernandez ME, Zaidi N, Sweeney JD. Heavy parasitemia in babesiosis treated without adjunctive red cell exchange. Transfus Apher Sci. 2019, 58:439-41. 10.1016\/j.transci.2019.04.026","journal-title":"Transfus Apher Sci"},{"key":"ref9","article-title":"Unusual case of pulmonary rickettsiosis in non-Hodgkin's lymphoma","volume":"88","author":"Pugliese C","year":"1997","unstructured":"Pugliese C, Parigi PC, Bamberga M, et al.. Unusual case of pulmonary rickettsiosis in non-Hodgkin's lymphoma. Minerva Med. 1997, 88:261-4.","journal-title":"Minerva Med"},{"key":"ref10","article-title":"Initial treatment of stage II to IV follicular lymphoma","author":"Freedman AS","year":"2022","unstructured":"Freedman AS, Friedberg JJW. Initial treatment of stage II to IV follicular lymphoma. UpToDate. Connor RF (ed): Wolters Kluwer, Philadelphia, PA; 2022."},{"key":"ref11","unstructured":"Rituximab (intravenous) including biosimilars. drug information. (1978). Accessed: February 27 2023: https:\/\/www.uptodate.com\/contents\/rituximab-intravenous-including-biosimilars-drug-information?search=rituximab+lymph...."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2012.03.007","article-title":"Babesiosis","volume":"58","author":"Kavanaugh MJ","year":"2012","unstructured":"Kavanaugh MJ, Decker CF. Babesiosis. Dis Mon. 2012, 58:355-60. 10.1016\/j.disamonth.2012.03.007","journal-title":"Dis Mon"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10111430","article-title":"Ticks, human babesiosis and climate change","volume":"10","author":"Gray JS","year":"2021","unstructured":"Gray JS, Ogden NH. Ticks, human babesiosis and climate change. Pathogens. 2021, 10:1430. 10.3390\/pathogens10111430","journal-title":"Pathogens"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v45i04a02","article-title":"N increased risk of tick-borne diseases with climate and environmental changes","volume":"45","author":"Bouchard C","year":"2019","unstructured":"Bouchard C, Dibernardo A, Koffi J, Wood H, Leighton P, Lindsay L. N increased risk of tick-borne diseases with climate and environmental changes. Can Commun Dis Rep. 2019, 45:83-9. 10.14745\/ccdr.v45i04a02","journal-title":"Can Commun Dis Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v43i10a01","article-title":"Surveillance for Lyme disease in Canada: 2009-2015","volume":"43","author":"Gasmi S","year":"2017","unstructured":"Gasmi S, Ogden NH, Lindsay LR, et al.. Surveillance for Lyme disease in Canada: 2009-2015. Can Commun Dis Rep. 2017, 43:194-9. 10.14745\/ccdr.v43i10a01","journal-title":"Can Commun Dis Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13339","article-title":"Seroprevalence of Babesia microti infection in Canadian blood donors","volume":"56","author":"O'Brien SF","year":"2016","unstructured":"O'Brien SF, Delage G, Scalia V, et al.. Seroprevalence of Babesia microti infection in Canadian blood donors. Transfusion. 2016, 56:237-43. 10.1111\/trf.13339","journal-title":"Transfusion"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/199039-a-presentation-of-babesiosis-in-the-setting-of-low-grade-follicular-b-cell-lymphoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:25Z","timestamp":1707509545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/199039-a-presentation-of-babesiosis-in-the-setting-of-low-grade-follicular-b-cell-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.52585","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,19]]}}}